Abstract
Oral JAK inhibitor baricitinib effective in JIA.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1038/s41584-023-01019-y
Copy DOIJournal: Nature reviews. Rheumatology | Publication Date: Aug 2, 2023 |
Oral JAK inhibitor baricitinib effective in JIA.
Join us for a 30 min session where you can share your feedback and ask us any queries you have